AI AGENTS
✳
DOCUMENTS AT SCALEHUMAN REVIEW ✓WORKFLOW CONNECTEDAI Agents
Discover how Narrativa uses AI Agents to transform Life Sciences documentation workflows.
↗ NARRATIVA NAVIGATOR · AGENTIC AI PLATFORM
Narrativa
Navigator
Agentic AI for life sciences documentation
Narrativa Navigator brings together purpose-built AI agents and connected workflows to help pharma and life sciences teams create high-volume documentation with speed, accuracy, and consistency—while keeping expert review and compliance at the center.
AI AGENTS TRUSTED BY LIFE SCIENCES ORGANIZATIONS
FOUR AGENTIC AI SOLUTIONS
Purpose-built agents
for life sciences.
A network of specialized AI agents supports compliant documentation, biostatistical development, patient narratives, and secure redaction across life sciences. Together, they help teams scale high-volume work, reduce repetitive effort, and maintain expert oversight from first draft through review.
MEDICAL AUTHORING COMPANION
Submission-ready documents across the drug lifecycle.
The Medical Authoring Companion is comprised of a network of proprietary AI agents that enable teams to create and review compliant, submission-ready medical and regulatory documents across the end-to-end drug development lifecycle.
BIOSTAT DEVELOPER
From study design through analysis.
The BioStat Developer AI Agent accelerates end-to-end biostatistical development–from study design and statistical programming to analysis.
NARRATIVES PATHWAY
Patient narratives at scale.
The Narratives Pathway AI Agent transforms clinical data into clear, consistent, submission-ready patient narratives—automating thousands at scale with speed and consistency.
REDACTION SCOUT
Privacy protection across documents and data.
Redaction Scout AI agents automate the detection, anonymization, and redaction of sensitive information across documents and data sets—quickly, consistently, and securely.
NARRATIVA NAVIGATOR · THE PLATFORM
Connected capabilities.
One trusted platform.
Narrativa Navigator brings together purpose-built AI solutions, specialist AI agents, platform features, a Knowledge Graph, security and privacy controls, compliance, and flexible infrastructure for regulated life sciences work.
PLATFORM
◉EvidenceSource data
⌘GenerateAI workflow✓
✳ReviewHuman oversight
Document generation •••
Features
Purpose-built features support complex document generation from source material through review.
KNOWLEDGE
AI
QA
RA
SME
Source-linkedKnowledge graphKnowledge Graph
Connect trusted knowledge and evidence to the content your teams create.
Explore Knowledge GraphSECURITY
✓
ACCESS CONTROLLEDPRIVACY BY DESIGNDATA PROTECTEDSecurity & privacy
Privacy-by-design practices and a HIPAA-ready architecture for sensitive life sciences data.
Explore Data, privacy & securityGOVERNANCE
◉PoliciesRisk based
✓ControlsTraceable✓
✳ComplianceGxP ready
Governed workflows •••
Compliance
Validation-ready architecture for GxP-regulated workflows and responsible AI practices.
↗INFRASTRUCTURE
EU
US
GxP
AI
Built to scaleRegulated by designInfrastructure
Scalable infrastructure designed to support the demands of regulated life sciences work.
Explore InfrastructureSUCCESS STORIES
Trusted by leading
companies.
Real stories of Life Sciences teams accelerating regulatory and clinical documentation with Narrativa Navigator. Explore how organizations scale complex workflows, reduce manual effort, and keep expert review at the center.
TOP PHARMA
PATIENT NARRATIVES / IMPACT
REGULATORY / DOCUMENTATIONLATEST ARTICLES
Insights for
life sciences.
Gain insights into the life sciences regulatory landscape and discover solutions, innovations, and practical updates powered by Narrativa Navigator. Explore fresh perspectives on regulatory change, workflow innovation, and applying agentic AI across the drug lifecycle.
OCTOBER 15, 2026
Why SOC 2 and ISO 27001 matter in Life Sciences
SOC 2 and ISO 27001 are crucial for ensuring security and compliance in the Life Sciences sector.
Read article
OCTOBER 8, 2026
Agentic AI for patient data processing and programming in clinical trials
Agentic AI can enhance clinical data workflows by automating tasks while ensuring traceability and maintaining human oversight.
Read article
OCTOBER 1, 2026
How medical writers can communicate with AI agents
Medical writers should clearly define the objective, authoritative sources, context, constraints, expected output and verification.
Read article
SEPTEMBER 22, 2026
AI governance in pharma: how to build a practical framework
AI governance in pharma establishes the framework for consistent, transparent, and accountable AI use within regulated workflows.
Read article
SEPTEMBER 15, 2026
Narrativa launches TivaSync, a new Agentic AI Growth Company for regulated industries, in partnership with Convertr
TivaSync is an Agentic AI Growth Company focused on Synchronized Intelligence to enhance B2B marketing and demand generation.
Read article
SEPTEMBER 8, 2026
Why healthcare AI pilots fail and how to move AI into production
Healthcare AI pilots often fail to transition into production due to challenges in data integration, human oversight, and governance.
Read articleAGENTIC AI FOR PHARMA & LIFE SCIENCES
Narrativa
Navigator.
Narrativa Navigator is Narrativa’s agentic AI platform for transforming how pharma, biotech, and life sciences organizations create complex documentation for regulatory and commercialization workflows.
By generating accurate, human-quality language at scale, these solutions streamline the creation of clinical study reports, patient narratives, regulatory submissions, and commercial content—delivering speed, consistency, and compliance across all workflows.
For regulatory teams, Narrativa Agentic AI analyzes large volumes of clinical data to produce clear, structured narratives, reducing manual effort while ensuring documents meet strict regulatory standards. For commercialization, it supports the rapid generation of high-quality materials, helping life sciences companies communicate insights, approvals, and product information efficiently. With Narrativa’s agentic AI, organizations can accelerate submissions, maintain compliance, and bring therapies to market faster.